FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025513370> ?p ?o ?g. }

• W2025513370 endingPage "643" @default.
• W2025513370 startingPage "643" @default.
• W2025513370 abstract "A first approach to discover new antimalarials has been recently performed in a combined approach with data from GlaxoSmithKline Tres Cantos Antimalarial Set, Novartis-GNF Malaria Box Data set and St. Jude Children’s Research Hospital. These data are assembled in the Malaria Box. In a first phenotypic forward chemical genetic approach, 400 chemicals were employed to eradicate the parasite in the erythrocytic stages. The advantage of phenotypic screens for the identification of novel chemotypes is that no a priori assumptions are made concerning a fixed target and that active compounds inherently have cellular bioavailability. In a first screen 40 mostly heterocyclic, highly active compounds (in nmol range of growth inhibition) were identified with EC50 values B2 lM against chloroquine-resistant Plasmodium falciparum strains and a therapeutic window C10 against two mammalian cell lines. 78 % of the compounds had no violations with the Lipinski Rule of 5 and only 1 % of the compounds showed cytotoxicity when applied at concentrations of 10 lM. This pre-selective step of parasitic eradication will be used further for a test of the Malaria Box with a potential in iron chelating capacity to inhibit deoxyhypusine hydroxylase (DOHH) from P. falciparum and vivax. DOHH, a metalloprotein which consists of ferrous iron and catalyzes the second step of the posttranslational modification at a specific lysine in eukaryotic initiation factor 5A (EIF-5A) to hypusine. Hypusine is a novel, non-proteinogenic amino acid, which is essential in eukaryotes and for parasitic proliferation. DOHH seems to be a ‘‘druggable’’ target, since it has only 26 % amino acid identity to its human orthologue. For a High-throughput Screening (HTS) of DOOH inhibitors, rapid and robust analytical tools are a prerequisite. A proteomic platform for the detection of hypusine metabolites is currently established. Ultra performance Liquid Chromatography enables the detection of hypusine metabolites with retention times of 7.4 min for deoxyhypusine and 7.3 min for hypusine. Alternatively, the analytes can be detected by their masses with gas chromatography/mass spectrometry or onedimensional chromatography coupled to mass spectrometry. Moreover, the identified hits will be tracked further to test their efficacy in novel ‘‘in vitro assays’’. Subsequently in vivo inhibition in a humanized mouse model will be tested." @default.
• W2025513370 created "2016-06-24" @default.
• W2025513370 creator A5016751135 @default.
• W2025513370 creator A5039446944 @default.
• W2025513370 date "2014-02-07" @default.
• W2025513370 modified "2023-10-18" @default.
• W2025513370 title "Erratum to: Chemical profiling of deoxyhypusine hydroxylase inhibitors for antimalarial therapy" @default.
• W2025513370 doi "https://doi.org/10.1007/s00726-014-1689-z" @default.
• W2025513370 hasPublicationYear "2014" @default.
• W2025513370 type Work @default.
• W2025513370 sameAs 2025513370 @default.
• W2025513370 citedByCount "0" @default.
• W2025513370 crossrefType "journal-article" @default.
• W2025513370 hasAuthorship W2025513370A5016751135 @default.
• W2025513370 hasAuthorship W2025513370A5039446944 @default.
• W2025513370 hasBestOaLocation W20255133701 @default.
• W2025513370 hasConcept C111919701 @default.
• W2025513370 hasConcept C185592680 @default.
• W2025513370 hasConcept C187191949 @default.
• W2025513370 hasConcept C41008148 @default.
• W2025513370 hasConcept C70721500 @default.
• W2025513370 hasConcept C86803240 @default.
• W2025513370 hasConcept C98274493 @default.
• W2025513370 hasConceptScore W2025513370C111919701 @default.
• W2025513370 hasConceptScore W2025513370C185592680 @default.
• W2025513370 hasConceptScore W2025513370C187191949 @default.
• W2025513370 hasConceptScore W2025513370C41008148 @default.
• W2025513370 hasConceptScore W2025513370C70721500 @default.
• W2025513370 hasConceptScore W2025513370C86803240 @default.
• W2025513370 hasConceptScore W2025513370C98274493 @default.
• W2025513370 hasIssue "3" @default.
• W2025513370 hasLocation W20255133701 @default.
• W2025513370 hasOpenAccess W2025513370 @default.
• W2025513370 hasPrimaryLocation W20255133701 @default.
• W2025513370 hasRelatedWork W1964132410 @default.
• W2025513370 hasRelatedWork W2009329529 @default.
• W2025513370 hasRelatedWork W2062220403 @default.
• W2025513370 hasRelatedWork W2069949469 @default.
• W2025513370 hasRelatedWork W2162314707 @default.
• W2025513370 hasRelatedWork W2226498157 @default.
• W2025513370 hasRelatedWork W2318872205 @default.
• W2025513370 hasRelatedWork W2922700717 @default.
• W2025513370 hasRelatedWork W3010016401 @default.
• W2025513370 hasRelatedWork W4240908335 @default.
• W2025513370 hasVolume "46" @default.
• W2025513370 isParatext "false" @default.
• W2025513370 isRetracted "false" @default.
• W2025513370 magId "2025513370" @default.
• W2025513370 workType "erratum" @default.